Hosted on MSN18h
'We had to stop CPR on my 14-month-old - here's what triggered the difficult decision'
A husband and wife team from Minnesota have opened up about the fateful decision they had to make about their 14-month-old ...
Pharmabiz11h
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...
Large Clinical Study Highlights Eko Health's AI for Early Detection of Pulmonary Hypertension
Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...
Hosted on MSN2d
Akura enrols first subject in pulmonary embolism trial of thrombectomy system
Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
Managed Healthcare Executive22h
Right Heart Size Should be Part of PAH Risk Models, Study Suggests
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.
Managed Healthcare Executive2d
Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH
Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...
AlphaGalileo16h
Mechanical Thrombectomy System for the Treatment of Intermediate-Risk Acute Pulmonary Embolism: The CLEAR Study
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Business Wire11h
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the ...